← Back to Search

Cognitive Remediation

Goal Management Therapy for PTSD

N/A

Recruiting

Led By Margaret McKinnon, PhD

Research Sponsored by Homewood Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

have a diagnosis of post-traumatic stress disorder on the Clinician Administered PTSD Scale (CAPS)

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up phase 1 (inpatient): baseline, post-intervention at 3 weeks.

Awards & highlights

No Placebo-Only Group

Summary

This trial looks at whether a cognitive therapy called Goal Management Therapy can help improve PTSD symptoms in public safety personnel.

Who is the study for?

This trial is for public safety personnel who have been diagnosed with PTSD using the CAPS scale and can give written consent. It's not specified who cannot participate, so additional exclusion criteria may apply.

What is being tested?

The study tests Goal Management Therapy (GMT), a method to improve goal-directed behavior and executive functioning in those with PTSD, compared to psychosocial education.

What are the potential side effects?

Since GMT is a type of cognitive therapy and psychosocial education involves learning strategies, side effects are likely minimal but could include temporary increases in stress or anxiety.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with PTSD by a professional.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ phase 1 (inpatient): administered during week 1, week 3, week 6, and week 9 of the intervention and at 3 months post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~phase 1 (inpatient): administered during week 1, week 3, week 6, and week 9 of the intervention and at 3 months post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and phase 1 (inpatient): administered during week 1, week 3, week 6, and week 9 of the intervention and at 3 months post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Advanced Clinical Solutions Test of Premorbid Functioning (TOPF)

Change from Baseline in Score on the Cognitive Failures Questionnaire (CFQ) at 3 weeks post-intervention and 3 months post-intervention

Change from Baseline in Score on the VOT Hooper Visual Organization Test at 3 weeks post-intervention

+14 more

Secondary study objectives

Change from baseline in score on the Depression and Anxiety Stress Scale (DASS-21) at post-intervention

Change from baseline in score on the Difficulties in Emotion Regulation Scale (DERS) at post-intervention

Change from baseline in score on the Moral Injury Assessment for Public Safety Personnel (MIA-PSP) at post-intervention

+34 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Goal Management TherapyExperimental Treatment1 Intervention

Goal Management Therapy is a structured, short-term, present-oriented cognitive remediation program with emphasis on mindfulness and practice in planning and completion of goal-oriented behaviors. The primary objective of GMT is to train patients to interrupt ongoing behavior through the resumption of executive control in order to define goal hierarchies and monitor performance in achieving goals. Sessions include instructional material, interactive tasks, discussion of patients' real-life deficits, and homework assignments. Phase 1: Inpatients will attend group sessions twice per week for 3 weeks, each session being 2 hours in length. Phase 2: Outpatients from the community will attend 1 session per week for 9 weeks, each session being 2 hours in length. Phase 3: Outpatients from the community will attend 1 session per week for 9 weeks, each session being 2 hours in length.

Group II: Psychosocial EducationActive Control1 Intervention

Psychosocial education will provide participants with educational materials (e.g., brain function, neuroplasticity) and lifestyle interventions (e.g., sleep hygiene, stress, exercise). They will be matched for length and for amount of facilitator contact with the Goal Management Therapy sessions. Phase 1: Inpatients will attend group sessions twice per week for 3 weeks, each session being 2 hours in length. Phase 2: Outpatients from the community will attend 1 session per week for 9 weeks, each session being 2 hours in length. Phase 3: Outpatients from the community will attend 1 session per week for 9 weeks, each session being 2 hours in length.

0 / 1Eligibility criteria met